Vasopressin als Reservevasopressor

[1]  H. Mann,et al.  Update on the management of cardiogenic shock , 2006, Current opinion in critical care.

[2]  P. Radermacher,et al.  Catecholamines and vasopressin during critical illness. , 2006, Endocrinology and metabolism clinics of North America.

[3]  H. Ross,et al.  Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. , 2005, The American journal of cardiology.

[4]  V. Wenzel,et al.  Arginine vasopressin in 316 patients with advanced vasodilatory shock* , 2005, Critical care medicine.

[5]  M. Gheorghiade,et al.  Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. , 2005, The American journal of cardiology.

[6]  C. Hogue,et al.  Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol. , 2004, Anesthesia and analgesia.

[7]  W. Schobersberger,et al.  Does Arginine Vasopressin Influence the Coagulation System in Advanced Vasodilatory Shock with Severe Multiorgan Dysfunction Syndrome? , 2004, Anesthesia and analgesia.

[8]  P. Factor,et al.  Role of vasopressin in the management of septic shock , 2004, Intensive Care Medicine.

[9]  S. Ho,et al.  Low-dose vasopressin infusion can be an alternative in treating patients with refractory septic shock combined with chronic pulmonary hypertension--a case report. , 2003, Acta anaesthesiologica Sinica.

[10]  M. Dünser,et al.  Arginine Vasopressin in Advanced Vasodilatory Shock: A Prospective, Randomized, Controlled Study , 2003, Circulation.

[11]  M. Westphal,et al.  Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport , 2003, Intensive Care Medicine.

[12]  P. Wouters,et al.  Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension* , 2002, Critical care medicine.

[13]  M. Dünser,et al.  Cardiac performance during vasopressin infusion in postcardiotomy shock , 2002, Intensive Care Medicine.

[14]  D. Landry,et al.  The pathogenesis of vasodilatory shock. , 2001, The New England journal of medicine.

[15]  M. Dünser,et al.  The Effects of Vasopressin on Systemic Hemodynamics in Catecholamine-Resistant Septic and Postcardiotomy Shock: A Retrospective Analysis , 2001, Anesthesia and analgesia.

[16]  M. Oz,et al.  Vasopressin as an alternative to norepinephrine in the treatment of milrinone‐induced hypotension , 2000, Critical care medicine.

[17]  M. Oz,et al.  Vasopressin pressor hypersensitivity in vasodilatory septic shock. , 1997, Critical care medicine.

[18]  B. Walker,et al.  Enhanced pulmonary arterial dilation to arginine vasopressin in chronically hypoxic rats. , 1994, The American journal of physiology.

[19]  H. Schaff,et al.  Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. , 1993, Chest.